Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
| Company | Current Parent | Current Parent Industry  | Primary Offense Type | Year | Agency | Penalty Amount |
|---|---|---|---|---|---|---|
| GARDA WORLD CASH LOGISTICS - FRESNO BRANCH 29 | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2018 | OSHA | $18,270 |
| GARDA CL WEST INC | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2018 | OSHA | $22,650 |
| PETSMART STORE #1808 | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2018 | OSHA | $5,936 |
| PETSMART, INC. | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2018 | OSHA | $5,543 |
| CHEWY, INC. | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2018 | OSHA | $14,323 |
| GARDA CL CENTRAL INC | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2019 | OSHA | $20,000 |
| GARDA CL WEST, INC. | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2019 | OSHA | $8,525 |
| GARDAWORLD | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2019 | OSHA | $62,328 |
| PET SMART, INC. | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2020 | OSHA | $12,337 |
| GARDA CL CENTRAL INC | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2020 | OSHA | $6,300 |
| PETSMART LLC | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2021 | OSHA | $7,303 |
| CHEWY, INC. | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2021 | OSHA | $5,851 |
| GARDAWORLD | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2022 | OSHA | $6,216 |
| PETSMART | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2022 | OSHA | $6,215 |
| CHEWY, INC | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2023 | OSHA | $10,000 |
| PETSMART DISTRIBUTION CENTER | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2023 | OSHA | $24,000 |
| PETSMART DISTRIBUTION CENTER 41 | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2023 | OSHA | $9,330 |
| PETSMART | BC Partners | private equity (including portfolio companies) | workplace safety or health violation | 2024 | OSHA | $8,850 |
| PETSMART HOME OFFICE, INC | BC Partners | private equity (including portfolio companies) | environmental violation | 2023 | EPA | $30,000 |
| PETSMART, INCORPORATED | BC Partners | private equity (including portfolio companies) | environmental violation | 2002 | EPA | $42,322 |
| PetSmart, Inc. | BC Partners | private equity (including portfolio companies) | environmental violation | 2012 | EPA | $156,000 |
| AstraZeneca LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | FDA | $520,000,000 |
| GlaxoSmithKline Vaccines | GlaxoSmithKline | pharmaceuticals | air pollution violation | 2014 | EPA | $172,900 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | hazardous waste violation | 2014 | EPA | $317,550 |
| AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | DOJ_CIVIL | $46,500,000 |
| Roxane Laboratories Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2010 | DOJ_CIVIL | $280,000,000 |
| AstraZeneca Pharmaceuticals | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2005 | DOJ_CIVIL | $150,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $354,900,000 |
| AstraZeneca PLC | AstraZeneca | pharmaceuticals | kickbacks and bribery | 2016 | SEC | $5,522,000 |
| GlaxoSmithKline plc | GlaxoSmithKline | pharmaceuticals | kickbacks and bribery | 2016 | SEC | $20,000,000 |
| SmithKline Beecham | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | DOJ_CIVIL | $47,000,000 |
| Aegerion Pharmaceuticals | Amryt Pharma | pharmaceuticals | investor protection violation | 2017 | SEC | $4,100,000 |
| GLAXO SMITH KLINE | GlaxoSmithKline | pharmaceuticals | aviation safety violation | 2014 | FAA | $59,500 |
| Aegerion Pharmaceuticals Inc. | Amryt Pharma | pharmaceuticals | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,700,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2004 | FL-AG | $807,826 |
| AstraZeneca | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | KY-AG | $5,500,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | consumer protection violation | 2010 | KY-AG | $5,391,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $14,700,000 |
| AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,900,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993 |
| AstraZeneca Pharmaceuticals LP and AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $2,500,000 |
| AstraZeneca Pharmaceuticals, LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
| Boehringer Ingelheim Roxane, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2008 | MA-AG | $1,800,000 |
| Boehringer Ingelheim Roxane, Inc. et al. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $477,792,391 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2006 | GA-AG | $418,952 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $14,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2006 | MULTI-AG | $3,500,000 |
| GlaxoSmithKline, LLC | GlaxoSmithKline | pharmaceuticals | drug or medical equipment safety violation | 2011 | MULTI-AG | $40,750,000 |
| Roxane Laboratories Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $2,400,000 |
| Roxane Laboratories, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | FL-AG | $8,500,000 |
| Roxane Laboratories, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
| Roxane, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2010 | MO-AG | $3,100,000 |
| Roxanne Laboratories and Boehringer Ingelheim | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $9,500,000 |
| SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
| SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2019 | IL-AG | $54,653,931 |
| GlaxoSmithKline Holdings (Americas) | GlaxoSmithKline | pharmaceuticals | tax violations | 2006 | IRS | $3,400,000,000 |
| GLAXOSMITHKLINE LLC | GlaxoSmithKline | pharmaceuticals | environmental violation | 2016 | PA-ENV | $5,259 |
| GlaxoSmithKline LLC | GlaxoSmithKline | pharmaceuticals | environmental violation | 2015 | NY-ENV | $24,200 |
| AstraZeneca | AstraZeneca | pharmaceuticals | employment discrimination | 2021 | OFCCP | $560,000 |
| AstraZeneca | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $24,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $11,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | private lawsuit-federal | $20,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $13,000,000 |
| AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | price-fixing or anti-competitive practices | 2011 | private lawsuit-federal | $90,000,000 |
| GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $75,000,000 |
| GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2013 | private lawsuit-federal | $21,500,000 |
| GlaxoSmithKline PLC | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $70,000,000 |
| Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | MULTI-AG | $102,500,000 |
| Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | private lawsuit-federal | $30,000,000 |
| Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2024 | private lawsuit-federal | $385,000,000 |
| ALEXION PHARMACEUTICALS, INC. | AstraZeneca | pharmaceuticals | workplace safety or health violation | 2012 | OSHA | $8,213 |
| HIKMA PHARMACEUTICALS | Hikma Pharmaceuticals | pharmaceuticals | workplace safety or health violation | 2020 | OSHA | $20,479 |
| GLAXOSMITHKLINE, LLC | GlaxoSmithKline | pharmaceuticals | hazardous waste violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $317,550 |
| MEDIMMUNE DISTRIBUTION LLC | AstraZeneca | pharmaceuticals | environmental violation | 2005 | EPA | $21,125 |
| ASTRAZENECA PLP | AstraZeneca | pharmaceuticals | environmental violation | 2021 | EPA | $18,960 |
| GLAXOSMITHKLINE VACCINES | GlaxoSmithKline | pharmaceuticals | air pollution violation | 2014 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $172,900 |
| DS SMITH | DS Smith PLC | paper and packaging | workplace safety or health violation | 2019 | OSHA | $13,047 |
| Noble Drilling (U.S.) LLC | Noble Corp. | oilfield services and supplies | environmental violation | 2014 | DOJ | $12,200,000 |
| Rowan Companies, Inc. | Valaris | oilfield services and supplies | environmental violation | 2007 | EPA | $9,000,000 |
| FOSTER WHEELER, INC. | Wood Group | oilfield services and supplies | labor relations violation | 2001 | NLRB | $19,986 |
| FOSTER WHEELER MT CARMEL INC | Wood Group | oilfield services and supplies | environmental violation | 2002 | PA-ENV | $55,225 |
| Foster Wheeler Robbins, Inc., Foster Wheeler Illinois, Inc., and Robbins Resource Recovery Partners, L.P. | Wood Group | oilfield services and supplies | air pollution violation | 2002 | IL-ENV | $450,000 |
| AMEC | Wood Group | oilfield services and supplies | workplace safety or health violation | 2001 | OSHA | $7,000 |
| ROWAN COMPANIES, INC., ROWAN GORILLA III | Valaris | oilfield services and supplies | workplace safety or health violation | 2011 | OSHA | $9,000 |
| ROWAN COMPANIES, INC. - RIG #54 | Valaris | oilfield services and supplies | workplace safety or health violation | 2010 | OSHA | $9,165 |
| NOBLE DRILLING SERVICES, INC. | Noble Corp. | oilfield services and supplies | workplace safety or health violation | 2012 | OSHA | $8,000 |
| Foster Wheeler North America Corporation | Wood Group | oilfield services and supplies | PCB violation | 2009 | EPA | $5,400 |
| Equilon Enterprises | Shell PLC | oil and gas | air pollution violation | 2015 | EPA | $900,000 |
